Single-injection  ||| S:0 E:17 ||| JJ
glucose  ||| S:17 E:25 ||| JJ
kinetics  ||| S:25 E:34 ||| NN
with  ||| S:34 E:39 ||| IN
compartmental  ||| S:39 E:53 ||| JJ
modelling  ||| S:53 E:63 ||| NN
during  ||| S:63 E:70 ||| IN
rest  ||| S:70 E:75 ||| NN
and  ||| S:75 E:79 ||| CC
low-intensity  ||| S:79 E:93 ||| JJ
exercise  ||| S:93 E:102 ||| NN
in  ||| S:102 E:105 ||| IN
horses  ||| S:105 E:112 ||| JJ
Tools  ||| S:112 E:118 ||| NNP
and  ||| S:118 E:122 ||| CC
criteria  ||| S:122 E:131 ||| NNS
to  ||| S:131 E:134 ||| TO
evaluate  ||| S:134 E:143 ||| VB
and  ||| S:143 E:147 ||| CC
understand  ||| S:147 E:158 ||| VB
glucose  ||| S:158 E:166 ||| JJ
metabolism  ||| S:166 E:177 ||| NNS
are  ||| S:177 E:181 ||| VBP
essential  ||| S:181 E:191 ||| JJ
to  ||| S:191 E:194 ||| TO
optimise  ||| S:194 E:203 ||| VB
equine  ||| S:203 E:210 ||| JJ
energy  ||| S:210 E:217 ||| NN
utilisation  ||| S:217 E:229 ||| NN
for  ||| S:229 E:233 ||| IN
exercise  ||| S:233 E:242 ||| NN
performance  ||| S:242 E:254 ||| NN
and  ||| S:254 E:258 ||| CC
reduced  ||| S:258 E:266 ||| VBD
metabolic  ||| S:266 E:276 ||| JJ
health  ||| S:276 E:283 ||| NN
risks ||| S:283 E:288 ||| NNS
.  ||| S:288 E:290 ||| .
To  ||| S:290 E:293 ||| TO
re-evaluate  ||| S:293 E:305 ||| VB
models  ||| S:305 E:312 ||| NNS
of  ||| S:312 E:315 ||| IN
glucose  ||| S:315 E:323 ||| JJ
kinetics  ||| S:323 E:332 ||| NN
in  ||| S:332 E:335 ||| IN
the  ||| S:335 E:339 ||| DT
horse  ||| S:339 E:345 ||| NN
at  ||| S:345 E:348 ||| IN
rest  ||| S:348 E:353 ||| NN
and  ||| S:353 E:357 ||| CC
during  ||| S:357 E:364 ||| IN
endurance  ||| S:364 E:374 ||| JJ
type  ||| S:374 E:379 ||| NN
exercise  ||| S:379 E:388 ||| NN
using  ||| S:388 E:394 ||| VBG
a  ||| S:394 E:396 ||| DT
single  ||| S:396 E:403 ||| JJ
injection  ||| S:403 E:413 ||| NN
technique  ||| S:413 E:423 ||| NN
and  ||| S:423 E:427 ||| CC
compartmental  ||| S:427 E:441 ||| JJ
modelling ||| S:441 E:450 ||| NN
.  ||| S:450 E:452 ||| .
Twelve  ||| S:452 E:459 ||| NNS
exercise  ||| S:459 E:468 ||| VBP
trained  ||| S:468 E:476 ||| VBN
Arabian  ||| S:476 E:484 ||| JJ
geldings  ||| S:484 E:493 ||| NN
received  ||| S:493 E:502 ||| VBD
a  ||| S:502 E:504 ||| DT
bolus  ||| S:504 E:510 ||| NN
of  ||| S:510 E:513 ||| IN
100  ||| S:513 E:517 ||| CD
µmol ||| S:517 E:521 ||| FW
/ ||| S:521 E:522 ||| FW
kg  ||| S:522 E:525 ||| FW
bwt  ||| S:525 E:529 ||| FW
[ ||| S:529 E:530 ||| -LRB-
6,6- ||| S:530 E:534 ||| NNP
( ||| S:534 E:535 ||| -LRB-
2 ||| S:535 E:536 ||| LS
)  ||| S:536 E:538 ||| -RRB-
H ||| S:538 E:539 ||| NNP
] ||| S:539 E:540 ||| -RRB-
glucose  ||| S:540 E:548 ||| VBD
i.v.  ||| S:548 E:553 ||| CD
while  ||| S:553 E:559 ||| NN
at  ||| S:559 E:562 ||| IN
rest  ||| S:562 E:567 ||| NN
and  ||| S:567 E:571 ||| CC
while  ||| S:571 E:577 ||| IN
running  ||| S:577 E:585 ||| VBG
at  ||| S:585 E:588 ||| IN
∼  ||| S:588 E:590 ||| CD
4  ||| S:590 E:592 ||| CD
m ||| S:592 E:593 ||| CD
/ ||| S:593 E:594 ||| CD
s  ||| S:594 E:596 ||| NN
on  ||| S:596 E:599 ||| IN
a  ||| S:599 E:601 ||| DT
treadmill ||| S:601 E:610 ||| NN
.  ||| S:610 E:612 ||| .
Tracer  ||| S:612 E:619 ||| NNP
and  ||| S:619 E:623 ||| CC
tracee  ||| S:623 E:630 ||| JJ
glucose  ||| S:630 E:638 ||| JJ
curves  ||| S:638 E:645 ||| NN
from  ||| S:645 E:650 ||| IN
4-150  ||| S:650 E:656 ||| CD
min  ||| S:656 E:660 ||| NN
after  ||| S:660 E:666 ||| IN
the  ||| S:666 E:670 ||| DT
bolus  ||| S:670 E:676 ||| JJ
dose  ||| S:676 E:681 ||| NN
( ||| S:681 E:682 ||| -LRB-
while  ||| S:682 E:688 ||| IN
the  ||| S:688 E:692 ||| DT
subject  ||| S:692 E:700 ||| NN
maintained  ||| S:700 E:711 ||| VBD
its  ||| S:711 E:715 ||| PRP$
resting  ||| S:715 E:723 ||| NN
or  ||| S:723 E:726 ||| CC
exercising  ||| S:726 E:737 ||| VBG
state ||| S:737 E:742 ||| NN
)  ||| S:742 E:744 ||| -RRB-
were  ||| S:744 E:749 ||| VBD
described  ||| S:749 E:759 ||| VBN
by  ||| S:759 E:762 ||| IN
a  ||| S:762 E:764 ||| DT
2  ||| S:764 E:766 ||| CD
term  ||| S:766 E:771 ||| NN
exponential  ||| S:771 E:783 ||| NN
decay  ||| S:783 E:789 ||| NN
curve ||| S:789 E:794 ||| NN
.  ||| S:794 E:796 ||| .
Compartmental  ||| S:796 E:810 ||| JJ
modelling  ||| S:810 E:820 ||| NN
was  ||| S:820 E:824 ||| VBD
performed  ||| S:824 E:834 ||| VBN
simultaneously  ||| S:834 E:849 ||| RB
for  ||| S:849 E:853 ||| IN
each  ||| S:853 E:858 ||| DT
horse ||| S:858 E:863 ||| NN
's  ||| S:863 E:866 ||| POS
resting  ||| S:866 E:874 ||| NN
and  ||| S:874 E:878 ||| CC
exercise  ||| S:878 E:887 ||| NN
curves  ||| S:887 E:894 ||| VBZ
using  ||| S:894 E:900 ||| VBG
an  ||| S:900 E:903 ||| DT
' ||| S:903 E:904 ||| POS
exercise  ||| S:904 E:913 ||| NN
effect ||| S:913 E:919 ||| NN
'  ||| S:919 E:921 ||| POS
parameter  ||| S:921 E:931 ||| NN
for  ||| S:931 E:935 ||| IN
each  ||| S:935 E:940 ||| DT
compartmental  ||| S:940 E:954 ||| JJ
exchange  ||| S:954 E:963 ||| NN
rate  ||| S:963 E:968 ||| NN
during  ||| S:968 E:975 ||| IN
exercise ||| S:975 E:983 ||| NN
.  ||| S:983 E:985 ||| .
Exercise  ||| S:985 E:994 ||| NN
increased  ||| S:994 E:1004 ||| VBD
all  ||| S:1004 E:1008 ||| DT
rate  ||| S:1008 E:1013 ||| NN
constants  ||| S:1013 E:1023 ||| NNS
and  ||| S:1023 E:1027 ||| CC
transport  ||| S:1027 E:1037 ||| NN
flows  ||| S:1037 E:1043 ||| NNS
for  ||| S:1043 E:1047 ||| IN
glucose  ||| S:1047 E:1055 ||| NN
between  ||| S:1055 E:1063 ||| IN
compartments  ||| S:1063 E:1076 ||| NN
by  ||| S:1076 E:1079 ||| IN
110-145 ||| S:1079 E:1086 ||| CD
%  ||| S:1086 E:1088 ||| NN
( ||| S:1088 E:1089 ||| -LRB-
P  ||| S:1089 E:1091 ||| NNP
≤  ||| S:1091 E:1093 ||| NNP
0.004 ||| S:1093 E:1098 ||| NNP
) ||| S:1098 E:1099 ||| -RRB-
.  ||| S:1099 E:1101 ||| .
Total  ||| S:1101 E:1107 ||| JJ
glucose  ||| S:1107 E:1115 ||| JJ
transport  ||| S:1115 E:1125 ||| NN
through  ||| S:1125 E:1133 ||| IN
the  ||| S:1133 E:1137 ||| DT
system  ||| S:1137 E:1144 ||| NN
increased  ||| S:1144 E:1154 ||| VBN
from  ||| S:1154 E:1159 ||| IN
8.9  ||| S:1159 E:1163 ||| CD
±  ||| S:1163 E:1165 ||| CD
0.6  ||| S:1165 E:1169 ||| CD
µmol ||| S:1169 E:1173 ||| FW
/ ||| S:1173 E:1174 ||| FW
min ||| S:1174 E:1177 ||| FW
/ ||| S:1177 E:1178 ||| FW
kg ||| S:1178 E:1180 ||| FW
/ ||| S:1180 E:1181 ||| FW
bwt  ||| S:1181 E:1185 ||| FW
at  ||| S:1185 E:1188 ||| IN
rest  ||| S:1188 E:1193 ||| NN
to  ||| S:1193 E:1196 ||| TO
25.0  ||| S:1196 E:1201 ||| CD
±  ||| S:1201 E:1203 ||| CD
1.1  ||| S:1203 E:1207 ||| CD
µmol ||| S:1207 E:1211 ||| FW
/ ||| S:1211 E:1212 ||| FW
min ||| S:1212 E:1215 ||| FW
/ ||| S:1215 E:1216 ||| FW
kg  ||| S:1216 E:1219 ||| FW
bwt  ||| S:1219 E:1223 ||| FW
during  ||| S:1223 E:1230 ||| IN
exercise  ||| S:1230 E:1239 ||| NN
( ||| S:1239 E:1240 ||| -LRB-
P  ||| S:1240 E:1242 ||| NNP
< ||| S:1242 E:1244 ||| SYM
0.001 ||| S:1244 E:1249 ||| NNP
) ||| S:1249 E:1250 ||| -RRB-
.  ||| S:1250 E:1252 ||| .
Exercise  ||| S:1252 E:1261 ||| NN
decreased  ||| S:1261 E:1271 ||| VBD
the  ||| S:1271 E:1275 ||| DT
volume  ||| S:1275 E:1282 ||| NN
of  ||| S:1282 E:1285 ||| IN
the  ||| S:1285 E:1289 ||| DT
primary  ||| S:1289 E:1297 ||| JJ
glucose  ||| S:1297 E:1305 ||| JJ
compartment  ||| S:1305 E:1317 ||| NN
by  ||| S:1317 E:1320 ||| IN
8 ||| S:1320 E:1321 ||| CD
%  ||| S:1321 E:1323 ||| NN
( ||| S:1323 E:1324 ||| -LRB-
P  ||| S:1324 E:1326 ||| NN
=  ||| S:1326 E:1328 ||| SYM
0.006 ||| S:1328 E:1333 ||| CD
)  ||| S:1333 E:1335 ||| -RRB-
and  ||| S:1335 E:1339 ||| CC
increased  ||| S:1339 E:1349 ||| VBD
plasma  ||| S:1349 E:1356 ||| JJ
glucose  ||| S:1356 E:1364 ||| JJ
clearance  ||| S:1364 E:1374 ||| NN
rate  ||| S:1374 E:1379 ||| NN
by  ||| S:1379 E:1382 ||| IN
almost  ||| S:1382 E:1389 ||| RB
200 ||| S:1389 E:1392 ||| CD
%  ||| S:1392 E:1394 ||| NN
( ||| S:1394 E:1395 ||| -LRB-
P  ||| S:1395 E:1397 ||| NNP
< ||| S:1397 E:1399 ||| SYM
0.001 ||| S:1399 E:1404 ||| NNP
) ||| S:1404 E:1405 ||| -RRB-
.  ||| S:1405 E:1407 ||| .
Turnover  ||| S:1407 E:1416 ||| NN
times  ||| S:1416 E:1422 ||| NNS
and  ||| S:1422 E:1426 ||| CC
mean  ||| S:1426 E:1431 ||| JJ
residence  ||| S:1431 E:1441 ||| NN
times  ||| S:1441 E:1447 ||| NNS
were  ||| S:1447 E:1452 ||| VBD
decreased  ||| S:1452 E:1462 ||| VBN
approximately  ||| S:1462 E:1476 ||| RB
60 ||| S:1476 E:1478 ||| CD
%  ||| S:1478 E:1480 ||| NN
by  ||| S:1480 E:1483 ||| IN
exercise  ||| S:1483 E:1492 ||| NN
( ||| S:1492 E:1493 ||| -LRB-
P  ||| S:1493 E:1495 ||| NNP
< ||| S:1495 E:1497 ||| SYM
0.001 ||| S:1497 E:1502 ||| NNP
) ||| S:1502 E:1503 ||| -RRB-
,  ||| S:1503 E:1505 ||| ,
whilst  ||| S:1505 E:1512 ||| JJ
turnover  ||| S:1512 E:1521 ||| NN
rates  ||| S:1521 E:1527 ||| NNS
were  ||| S:1527 E:1532 ||| VBD
increased  ||| S:1532 E:1542 ||| VBN
125 ||| S:1542 E:1545 ||| CD
%  ||| S:1545 E:1547 ||| NN
( ||| S:1547 E:1548 ||| -LRB-
P  ||| S:1548 E:1550 ||| NNP
< ||| S:1550 E:1552 ||| SYM
0.001 ||| S:1552 E:1557 ||| NNP
) ||| S:1557 E:1558 ||| -RRB-
.  ||| S:1558 E:1560 ||| .
Single-injection  ||| S:1560 E:1577 ||| JJ
tracer  ||| S:1577 E:1584 ||| JJ
kinetics  ||| S:1584 E:1593 ||| NN
and  ||| S:1593 E:1597 ||| CC
compartmental  ||| S:1597 E:1611 ||| JJ
modelling  ||| S:1611 E:1621 ||| NNS
represent  ||| S:1621 E:1631 ||| VBP
a  ||| S:1631 E:1633 ||| DT
valuable  ||| S:1633 E:1642 ||| JJ
tool  ||| S:1642 E:1647 ||| NN
to  ||| S:1647 E:1650 ||| TO
quantify  ||| S:1650 E:1659 ||| VB
tracee  ||| S:1659 E:1666 ||| JJ
availability  ||| S:1666 E:1679 ||| NN
to  ||| S:1679 E:1682 ||| TO
and  ||| S:1682 E:1686 ||| CC
use  ||| S:1686 E:1690 ||| NN
by  ||| S:1690 E:1693 ||| IN
tissue ||| S:1693 E:1699 ||| NN
.  ||| S:1699 E:1701 ||| .
This  ||| S:1701 E:1706 ||| DT
technique  ||| S:1706 E:1716 ||| NN
could  ||| S:1716 E:1722 ||| MD
represent  ||| S:1722 E:1732 ||| VB
a  ||| S:1732 E:1734 ||| DT
beneficial  ||| S:1734 E:1745 ||| JJ
tool  ||| S:1745 E:1750 ||| NN
for  ||| S:1750 E:1754 ||| IN
future  ||| S:1754 E:1761 ||| JJ
studies  ||| S:1761 E:1769 ||| NNS
exploring  ||| S:1769 E:1779 ||| VBG
the  ||| S:1779 E:1783 ||| DT
role  ||| S:1783 E:1788 ||| NN
of  ||| S:1788 E:1791 ||| IN
glucose  ||| S:1791 E:1799 ||| JJ
metabolism  ||| S:1799 E:1810 ||| NN
in  ||| S:1810 E:1813 ||| IN
equine  ||| S:1813 E:1820 ||| JJ
exercise  ||| S:1820 E:1829 ||| NN
performance  ||| S:1829 E:1841 ||| NN
and  ||| S:1841 E:1845 ||| CC
metabolic  ||| S:1845 E:1855 ||| JJ
disease ||| S:1855 E:1862 ||| NN
.  ||| S:1862 E:1864 ||| .
